Detecting 72 genes most commonly mutated in lung cancer

Detecting 72 genes most commonly mutated in lung cancer

December 14, 2016

Interested in the simultaneous detection of 72 genes most commonly mutated in lung cancer with high confidence? The newly developed Human Lung Cancer QIAseq DNA Panel provides you with a complete Sample to Insight solution and a simple, streamlined workflow.

The panel combines single primer extension (SPE) technology and unique molecular indices (UMIs) to enable sequencing of GC-rich regions, direct quantitation of CNVs, accurate expression level measurement and variant call validation. The simplicity of the system makes it ideal for routine known and novel lung cancer mutation detection on any NGS platform from Illumina and Ion Torrent.

Are you ready for Covid-19 Vaccine?

Are you ready for Covid-19 Vaccine?

The first COVID-19 vaccines are due to reach Lebanon in a matter of weeks and they require storage in Ultra-Low-Temperature Freezers to maintain safety and efficiency.

February 05, 2021 More +
New MASTR Facility supports adoption of NGS

New MASTR Facility supports adoption of NGS

Multiplicom is pleased to announce the new MASTR Facility to enable the implementation of massively parallel sequencing capabilities in clinical genetics and pathology laboratories.

September 15, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us